Skip to content

EMRI

Active
Private limited companyfounded 2017active for 9 yearsVogelzang 11, 8310 Brugge, BelgiumKBO/BCE: BE 0677.790.270
Summary

EMRI has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.5m and a net result of €459,720. Equity has been growing by about 49% per year since 2018. Its solvency ranks better than 58% of 3,032 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 28-06-2017 Normal situation
Activity
Dental practice NACE 86230
Establishment unit
2.266.550.993 8370 Blankenberge, since 03-07-2017
Financial year end
31 December
Peppol
Reachable since 03-01-2026

Board and ownership

Board
  • DEWULF TINEKEDirector

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€980,410
▲ 4.8%
Turnover
≈ €1.9m
estimated
Profit
€459,720
▲ 15.4%
Equity
€1.5m
▲ 36.7%
Total assets
€2.2m
▲ 14.4%
Employees on 31-12-2025
5
▲ 25.0%
Score breakdownraises risk1 change of registered office in 24 monthslowers riskSector: Human health activities (NACE 86)Figures for financial year 2025 (filed on 30-07-2026)Liquidity: current ratio 3.93, cash €299,434Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 56% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 93+11
equity 67.6% of total assets
Liquidity 62+13
short-term debt 18.5% · cash 13.9%
Profitability 95=
return on assets 21.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: 0.1% 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025lowest value 03-2025: 0.1%● unchanged vs 02-2025 04-2025: 0.1%● unchanged vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.1%● unchanged vs 07-2025 09-2025: 0.1%● unchanged vs 08-2025 10-2025: 0.1%● unchanged vs 09-2025 11-2025: 0.1%● unchanged vs 10-2025 12-2025: 0.2%▲ +0.1 percentage points vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.3%▲ +0.1 percentage points vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.4%▲ +0.1 percentage points vs 06-2026highest value 08-2026: 0.1%▼ -0.3 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026 11-2026: 0.1%● unchanged vs 10-2026
Credit of up to €130,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.93 (2.54 in 2024), above the usual 1.5. Short-term debt is 18.5% and cash 13.9% of total assets. 32.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 55% of them on solvency, 40% on liquidity, 54% on profitability and 75% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · 1 change of registered office in 24 months
Belgian Official Gazette
lowers risk · Figures for financial year 2025 (filed on 30-07-2026)
NBB · annual accounts
lowers risk · Liquidity: current ratio 3.93, cash €299,434
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-07-2026, 1 day ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
1 day early
2024
47 days late
2023
on the day
2022
32 days early
2021
60 days late
2020
3 days early
2019
23 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 13 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 1 August (4 of the last 5 accounts filed within 46 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 86% of companies in human healthsector median €110,426 · 2,998 companies €459,720 View
  • Positive: 8 profitable years in a rowprofit 2025: €459,720 8 years View
  • Positive: Equity rose in 2025from €1.1m to €1.5m ▲ 36.7% View

Recent changes

  1. · Gazette deed Registered office moved from Wingene to Sint-Kruis
  2. · Gazette deed Incorporation
All 17 events

Comparable companies

These companies have the same main activity as EMRI: dental practice (NACE 86230). They are comparable in size and age: total assets between €1.7m and €2.7m, founded between 2013 and 2020.

CompanyTotal assetsGross margin
EMRI Brugge€2.2m€1.0m
VIOLETTA TSERTANIDOU Genk€1.7m€0.9m
CDHC ROLAND Donceel€2.1m€1.2m
Catalpa Dilbeek€2.1m€1.3m
ORTHO PARO CONNECT Merelbeke-Melle€2.1m€0.9m
Miso-dent Zedelgem€2.5m€1.3m
Bianchi Ortho Elsene€2.7m€1.0m
Full comparison

Key facts about EMRI

What is the company number of EMRI?
The company number of EMRI is 0677.790.270. The VAT number is the same number with BE in front: BE 0677.790.270.
Where is EMRI based?
The registered office is at Vogelzang 11, 8310 Brugge.Company details
What does EMRI do?
According to the KBO register, the main activity is dental practice (NACE 86230).
What is the legal form of EMRI?
The legal form of EMRI is Private limited company (BV).
When was EMRI founded?
EMRI was founded on 28-06-2017.
Is EMRI still active?
Yes, EMRI is an active enterprise in the KBO register.
How many employees does EMRI have?
EMRI had an average of 3.6 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of EMRI?
The turnover in financial year 2025 is ≈ €1.9m. This figure is estimated from the gross margin of €980,410 and 40 comparable companies (NACE 862). It probably lies between €1.3m and €3.0m.
Is EMRI profitable?
In financial year 2025, EMRI made a profit of €459,720.
Where can I find the annual accounts of EMRI?
EMRI filed 9 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of EMRI due?
EMRI must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.